Bioengineering Advances and Cutting-edge Technology

    Research output: Chapter in Book/Report/Conference proceedingConference contribution

    Abstract

    There is a forty-year history of research collaboration by doctors at Tokyo Women's Medical University and engineers at Waseda University. The synergism culminated in 2008 with the establishment of the Center for Advanced Biomedical Sciences within the framework of the Tokyo Women's Medical University-Waseda University Joint Institution for Advanced Biomedical Sciences (TWIns). The center provides a singular environment for consolidating research in life science, bioengineering, and medicine. At first our new conceptual laboratories, called "DRY Lab" is introduced. There are three laboratories: Surgical Training Lab, GLP-compliant Lab and Medical Visualization Lab. These laboratories have a complement function of an animal (WET) laboratory. Secondly, an implantable centrifugal blood pump called EVAHEART as an exemplary product of this collaboration is introduced. Cardiac surgeon Kenji Yamazaki of Tokyo Women's Medical University, Sun Medical Technology Research Corporation, Waseda University, and the University of Pittsburgh originated the EVAHEART project in 1991. More than fifty companies contributed technologies that improved performance of the device. Teamwork between groups with divergent thinking and expertise led to optimized designs of components such as the impeller, shaft/seal mechanism, and blood-compatible materials. In clinical trials, fourteen of eighteen patients treated with EVAHEART had favorable postoperative outcomes. In the first case, the pump sustained the patient for more than three and one-half years. Among the four patients who died, none had a cause of death related to the device itself. Consequently, it is confirmed that this synergistic environment will help us create new scenarios and trials which are unconstrained by conventional knowledge.

    Original languageEnglish
    Title of host publicationIFMBE Proceedings
    Pages2143-2146
    Number of pages4
    Volume23
    DOIs
    Publication statusPublished - 2009
    Event13th International Conference on Biomedical Engineering, ICBME 2008 -
    Duration: 2008 Dec 32008 Dec 6

    Other

    Other13th International Conference on Biomedical Engineering, ICBME 2008
    Period08/12/308/12/6

    Fingerprint

    Blood
    Pumps
    Sun
    Medicine
    Seals
    Industry
    Animals
    Visualization
    Engineers
    Bioengineering

    Keywords

    • Biomedical engineering
    • Consolidating research
    • DRY Lab
    • EVAHEART
    • Implantable blood pump

    ASJC Scopus subject areas

    • Biomedical Engineering
    • Bioengineering

    Cite this

    Bioengineering Advances and Cutting-edge Technology. / Umezu, Mitsuo.

    IFMBE Proceedings. Vol. 23 2009. p. 2143-2146.

    Research output: Chapter in Book/Report/Conference proceedingConference contribution

    Umezu, M 2009, Bioengineering Advances and Cutting-edge Technology. in IFMBE Proceedings. vol. 23, pp. 2143-2146, 13th International Conference on Biomedical Engineering, ICBME 2008, 08/12/3. https://doi.org/10.1007/978-3-540-92841-6_535
    Umezu, Mitsuo. / Bioengineering Advances and Cutting-edge Technology. IFMBE Proceedings. Vol. 23 2009. pp. 2143-2146
    @inproceedings{47c92ec601d24983afbb43735d66e185,
    title = "Bioengineering Advances and Cutting-edge Technology",
    abstract = "There is a forty-year history of research collaboration by doctors at Tokyo Women's Medical University and engineers at Waseda University. The synergism culminated in 2008 with the establishment of the Center for Advanced Biomedical Sciences within the framework of the Tokyo Women's Medical University-Waseda University Joint Institution for Advanced Biomedical Sciences (TWIns). The center provides a singular environment for consolidating research in life science, bioengineering, and medicine. At first our new conceptual laboratories, called {"}DRY Lab{"} is introduced. There are three laboratories: Surgical Training Lab, GLP-compliant Lab and Medical Visualization Lab. These laboratories have a complement function of an animal (WET) laboratory. Secondly, an implantable centrifugal blood pump called EVAHEART as an exemplary product of this collaboration is introduced. Cardiac surgeon Kenji Yamazaki of Tokyo Women's Medical University, Sun Medical Technology Research Corporation, Waseda University, and the University of Pittsburgh originated the EVAHEART project in 1991. More than fifty companies contributed technologies that improved performance of the device. Teamwork between groups with divergent thinking and expertise led to optimized designs of components such as the impeller, shaft/seal mechanism, and blood-compatible materials. In clinical trials, fourteen of eighteen patients treated with EVAHEART had favorable postoperative outcomes. In the first case, the pump sustained the patient for more than three and one-half years. Among the four patients who died, none had a cause of death related to the device itself. Consequently, it is confirmed that this synergistic environment will help us create new scenarios and trials which are unconstrained by conventional knowledge.",
    keywords = "Biomedical engineering, Consolidating research, DRY Lab, EVAHEART, Implantable blood pump",
    author = "Mitsuo Umezu",
    year = "2009",
    doi = "10.1007/978-3-540-92841-6_535",
    language = "English",
    isbn = "9783540928409",
    volume = "23",
    pages = "2143--2146",
    booktitle = "IFMBE Proceedings",

    }

    TY - GEN

    T1 - Bioengineering Advances and Cutting-edge Technology

    AU - Umezu, Mitsuo

    PY - 2009

    Y1 - 2009

    N2 - There is a forty-year history of research collaboration by doctors at Tokyo Women's Medical University and engineers at Waseda University. The synergism culminated in 2008 with the establishment of the Center for Advanced Biomedical Sciences within the framework of the Tokyo Women's Medical University-Waseda University Joint Institution for Advanced Biomedical Sciences (TWIns). The center provides a singular environment for consolidating research in life science, bioengineering, and medicine. At first our new conceptual laboratories, called "DRY Lab" is introduced. There are three laboratories: Surgical Training Lab, GLP-compliant Lab and Medical Visualization Lab. These laboratories have a complement function of an animal (WET) laboratory. Secondly, an implantable centrifugal blood pump called EVAHEART as an exemplary product of this collaboration is introduced. Cardiac surgeon Kenji Yamazaki of Tokyo Women's Medical University, Sun Medical Technology Research Corporation, Waseda University, and the University of Pittsburgh originated the EVAHEART project in 1991. More than fifty companies contributed technologies that improved performance of the device. Teamwork between groups with divergent thinking and expertise led to optimized designs of components such as the impeller, shaft/seal mechanism, and blood-compatible materials. In clinical trials, fourteen of eighteen patients treated with EVAHEART had favorable postoperative outcomes. In the first case, the pump sustained the patient for more than three and one-half years. Among the four patients who died, none had a cause of death related to the device itself. Consequently, it is confirmed that this synergistic environment will help us create new scenarios and trials which are unconstrained by conventional knowledge.

    AB - There is a forty-year history of research collaboration by doctors at Tokyo Women's Medical University and engineers at Waseda University. The synergism culminated in 2008 with the establishment of the Center for Advanced Biomedical Sciences within the framework of the Tokyo Women's Medical University-Waseda University Joint Institution for Advanced Biomedical Sciences (TWIns). The center provides a singular environment for consolidating research in life science, bioengineering, and medicine. At first our new conceptual laboratories, called "DRY Lab" is introduced. There are three laboratories: Surgical Training Lab, GLP-compliant Lab and Medical Visualization Lab. These laboratories have a complement function of an animal (WET) laboratory. Secondly, an implantable centrifugal blood pump called EVAHEART as an exemplary product of this collaboration is introduced. Cardiac surgeon Kenji Yamazaki of Tokyo Women's Medical University, Sun Medical Technology Research Corporation, Waseda University, and the University of Pittsburgh originated the EVAHEART project in 1991. More than fifty companies contributed technologies that improved performance of the device. Teamwork between groups with divergent thinking and expertise led to optimized designs of components such as the impeller, shaft/seal mechanism, and blood-compatible materials. In clinical trials, fourteen of eighteen patients treated with EVAHEART had favorable postoperative outcomes. In the first case, the pump sustained the patient for more than three and one-half years. Among the four patients who died, none had a cause of death related to the device itself. Consequently, it is confirmed that this synergistic environment will help us create new scenarios and trials which are unconstrained by conventional knowledge.

    KW - Biomedical engineering

    KW - Consolidating research

    KW - DRY Lab

    KW - EVAHEART

    KW - Implantable blood pump

    UR - http://www.scopus.com/inward/record.url?scp=84891905980&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84891905980&partnerID=8YFLogxK

    U2 - 10.1007/978-3-540-92841-6_535

    DO - 10.1007/978-3-540-92841-6_535

    M3 - Conference contribution

    AN - SCOPUS:84891905980

    SN - 9783540928409

    VL - 23

    SP - 2143

    EP - 2146

    BT - IFMBE Proceedings

    ER -